Shri Dilip Bhuta was appointed as the Whole Time Director and CFO of Jenburkt Pharmaceuticals Ltd during the 36th Annual General Meeting held on September 7, 2021.
His appointment is for a period of five years, effective from April 1, 2022, to March 31, 2027.
His remuneration was approved for the period from April 1, 2022, to March 31, 2025, under a special resolution, and he is subject to retirement by rotation.
His Director Identification Number (DIN) is 03157252.
Dilip Bhuta is currently a Whole Time Director & CFO in Jenburkt Pharmaceuticals Ltd (as of Mar 2024).
Dilip Bhuta is serving the company - Jenburkt Pharmaceuticals Ltd at this position since 2017 for the last 8+ years.
Prior to becoming Whole Time Director & CFO, Dilip Bhuta was Whole-time Director of Jenburkt Pharmaceuticals Ltd for 2 years from 2015 to 2016.
FAQ's related Dilip Bhuta
Who is Dilip Bhuta
Shri Dilip Bhuta was appointed as the Whole Time Director and CFO of Jenburkt Pharmaceuticals Ltd during the 36th Annual General Meeting held on September 7, 2021. His appointment is for a period of five years, effective from April 1, 2022, to March 31, 2027. His remuneration was approved for the period from April 1, 2022, to March 31, 2025, under a special resolution, and he is subject to retirement by rotation. His Director Identification Number (DIN) is 03157252.
Which companies does Dilip Bhuta serve as a board member for?
Dilip Bhuta serves as a board member for: Jenburkt Pharmaceuticals Ltd
What positions has Dilip Bhuta held in his/her career?
Throughout their career, Dilip Bhuta has held key positions such as Whole Time Director & CFO,Whole-time Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.